278 related articles for article (PubMed ID: 31762828)
1. Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer.
Zhang SC; Hu ZQ; Long JH; Zhu GM; Wang Y; Jia Y; Zhou J; Ouyang Y; Zeng Z
J Cancer; 2019; 10(24):6175-6184. PubMed ID: 31762828
[TBL] [Abstract][Full Text] [Related]
2. Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
Bense RD; Sotiriou C; Piccart-Gebhart MJ; Haanen JBAG; van Vugt MATM; de Vries EGE; Schröder CP; Fehrmann RSN
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27737921
[TBL] [Abstract][Full Text] [Related]
3. Profiles of immune cell infiltration in head and neck squamous carcinoma.
Liang B; Tao Y; Wang T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
[TBL] [Abstract][Full Text] [Related]
4. Significance of Tumor-Infiltrating Immune Cells in the Prognosis of Colon Cancer.
Wu D; Ding Y; Wang T; Cui P; Huang L; Min Z; Xu M
Onco Targets Ther; 2020; 13():4581-4589. PubMed ID: 32547088
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer.
Ye L; Zhang T; Kang Z; Guo G; Sun Y; Lin K; Huang Q; Shi X; Ni Z; Ding N; Zhao KN; Chang W; Wang J; Lin F; Xue X
Front Immunol; 2019; 10():2368. PubMed ID: 31681276
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of PD-L1 expression in tumor infiltrating immune cells in cancers: A meta-analysis.
Zhao T; Li C; Wu Y; Li B; Zhang B
PLoS One; 2017; 12(4):e0176822. PubMed ID: 28453554
[TBL] [Abstract][Full Text] [Related]
7. Profiles of tumor-infiltrating immune cells in renal cell carcinoma and their clinical implications.
Zhu G; Pei L; Yin H; Lin F; Li X; Zhu X; He W; Gou X
Oncol Lett; 2019 Nov; 18(5):5235-5242. PubMed ID: 31612034
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Progesterone Receptor Status in Chinese Estrogen Receptor Positive Invasive Breast Cancer Patients.
Yao N; Song Z; Wang X; Yang S; Song H
J Breast Cancer; 2017 Jun; 20(2):160-169. PubMed ID: 28690652
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immune cell infiltration in bladder cancer: A gene expression-based study.
Wang Y; Ba HJ; Liu ZC; Deng XB; Zhou M
Oncol Lett; 2020 Aug; 20(2):1677-1684. PubMed ID: 32724410
[TBL] [Abstract][Full Text] [Related]
11. High tumor-infiltrating FoxP3
Qian F; Qingping Y; Linquan W; Xiaojin H; Rongshou W; Shanshan R; Wenjun L; Yong H; Enliang L
Eur J Surg Oncol; 2017 Jul; 43(7):1258-1264. PubMed ID: 28214052
[TBL] [Abstract][Full Text] [Related]
12. Patterns of immune infiltration and survival in endocrine therapy-treated ER-positive breast cancer: A computational study of 1900 patients.
Wang WQ; Zhang L; Yang F; Zhou HH; Zhang W; Zou Y; Liu R
Biomed Pharmacother; 2022 Nov; 155():113787. PubMed ID: 36271565
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.
Ali HR; Chlon L; Pharoah PD; Markowetz F; Caldas C
PLoS Med; 2016 Dec; 13(12):e1002194. PubMed ID: 27959923
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas.
Hsiao YW; Chiu LT; Chen CH; Shih WL; Lu TP
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31434354
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers.
Fujimoto Y; Watanabe T; Hida AI; Higuchi T; Miyagawa Y; Ozawa H; Bun A; Fukui R; Sata A; Imamura M; Hirota S; Miyoshi Y
Breast Cancer; 2019 Nov; 26(6):738-747. PubMed ID: 31098866
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.
Krishnamurti U; Wetherilt CS; Yang J; Peng L; Li X
Hum Pathol; 2017 Jun; 64():7-12. PubMed ID: 28153508
[TBL] [Abstract][Full Text] [Related]
17. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
18. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
19. Investigating the significance of tumor-infiltrating immune cells for the prognosis of lung squamous cell carcinoma.
Zhu Y; Zhang X
PeerJ; 2019; 7():e7918. PubMed ID: 31667016
[TBL] [Abstract][Full Text] [Related]
20. Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer.
Zhao CL; Singh K; Brodsky AS; Lu S; Graves TA; Fenton MA; Yang D; Sturtevant A; Resnick MB; Wang Y
BMC Cancer; 2019 Nov; 19(1):1036. PubMed ID: 31675929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]